Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients
- PMID: 1550161
- DOI: 10.1016/0002-9378(92)91359-i
Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients
Abstract
Objective: This study was undertaken to assess the impact of two low-dose oral contraceptive pills on compliance and side effects in adolescent patients.
Study design: The use of a levonorgestrel-containing triphasic pill (N = 114) was compared with that of a monophasic (1 + 35) norethindrone-containing pill (N = 110) at two different sociodemographic sites.
Results: No significant difference in compliance or pill satisfaction was observed between the pills. Socioeconomic factors were the overriding predictors of compliance. At 3 and 12 months of follow-up, there were significantly fewer complaints of overall side effects (p less than 0.001 and p = 0.004, respectively), breakthrough bleeding (p = 0.017 and p = 0.018), and pill amenorrhea (p = 0.002 and p less than 0.001) among users of the triphasic pill. Mean weight change at 12 months was +1.1 kg for the monophasic pill and -0.1 kg for the triphasic pill. All known pregnancies occurred among noncompliant city clinic patients.
Conclusions: Adolescents experienced fewer side effects with the triphasic pill than with the monophasic one, but compliance was the same.
PIP: This study was undertaken to assess the impact of 2 low-dose oral contraceptives (OCs) on compliance and side effects on adolescent patients. The use of a levonorgestrel-containing triphasic (n=114) was compared with that of a monophasic (1+35) norethindrone-containing pill (n=110) at 2 different sociodemographic sites. No significant difference in compliance or pill satisfaction was seen between the groups. Socioeconomic factors were the overriding predictors of compliance. At 3 and 12 months of followup, there were far fewer complaints of overall side effects (p0.001 and p=0.004, respectively), breakthrough bleeding (p=0.017 and p=0.018), and pill amenorrhea (p=0.002 and p0.001) among users of the triphasic pill. Mean weight change at 12 months was +1.1 kg for the monophasic pill group and -0.1 kg for the triphasic pill group. All known pregnancies occurred among noncompliant city clinic patients. Adolescents experienced fewer side effects with the triphasic pill than with the monophasic one, but compliance was the same.
Similar articles
-
A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.Contraception. 1993 Jan;47(1):43-54. doi: 10.1016/0010-7824(93)90108-j. Contraception. 1993. PMID: 8436001 Clinical Trial.
-
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.Contraception. 1995 Sep;52(3):143-9. doi: 10.1016/0010-7824(95)00153-2. Contraception. 1995. PMID: 7587185
-
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.Contraception. 1993 Jun;47(6):515-25. doi: 10.1016/0010-7824(93)90020-8. Contraception. 1993. PMID: 8334888 Clinical Trial.
-
Biphasic versus triphasic oral contraceptives for contraception.Contraception. 2002 May;65(5):321-4. doi: 10.1016/s0010-7824(01)00314-6. Contraception. 2002. PMID: 12057781
-
Contraception for women with diabetes: an update.Baillieres Clin Obstet Gynaecol. 1991 Jun;5(2):493-503. doi: 10.1016/s0950-3552(05)80109-9. Baillieres Clin Obstet Gynaecol. 1991. PMID: 1954724 Review.
Cited by
-
Patterns of oral contraceptive pill-taking and condom use among adolescent contraceptive pill users.J Adolesc Health. 2006 Sep;39(3):381-7. doi: 10.1016/j.jadohealth.2005.12.014. Epub 2006 Jul 10. J Adolesc Health. 2006. PMID: 16919800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources